Vaccines

Save lives. Manufacture effective vaccines quickly.

Are you prepared for the unpredictable?

Vaccine demands are a moving target; you need a production facility that responds quickly. New or existing, design and build flexibility and efficiency into your vaccine facility.

How can CRB help you?

Whether you need one compliant process that maximizes throughput or a configurable facility that can accommodate multiple operating scenarios, we have the vaccine manufacturing expertise to provide you a solution that checks all the boxes.

But speed and flexibility are second to cleanliness and regulatory compliance. Without that assurance, vaccines are as dangerous as the diseases they treat. Build confidence into your facility with our extensive regulatory knowledge and longstanding experience with clean facilities.

Public health relies on your vaccine production facility; you can rely on CRB.

Tell us more about your project.

HORIZONS

Download Now – Horizons: Life Sciences

Our 2022 edition of the life sciences report, built on the insights of nearly 500 industry leaders, explores the transformative change this field is poised to undergo in the wake of the pandemic and ever-increasing investment in R&D.

Download the Report

The Next Insights

View all Insights

Related Projects

View All Projects

What we do:

Biotechnology

Cell + Gene Therapy

Monoclonal Antibodies + Therapeutic Proteins

RNA Therapies

Seamlessly adopt new processes and produce higher quality therapeutics faster.

Stay ahead of the rapidly evolving biotech industry with a flexible facility and expertly designed process systems. You’ll be positioned to readily adapt to new advances while producing the best quality drug products quickly and cost-effectively.

Next-generation therapies now.

Achieve a facility that is flexible enough to continuously adopt technology which doesn’t yet exist, resilient enough to support rapid scale-up to commercialization, and advanced enough to keep you at the front of the race toward breakthrough autologous and allogeneic cell and gene therapies.

Manage a flexible, scalable product portfolio. Prepare for commercial success.

With competitors at your heels, speed-to-market pressure has never been higher for your mAbs or therapeutic proteins product. You need a flexible manufacturing asset that can quickly pivot within an uncertain product pipeline and unknown timeline.

Flexible RNA therapy facilities for a rapidly advancing sector.

Lead the way for this revolutionary technology with design and construction solutions that right-size your process, help you navigate a complex regulatory environment, and create a flexible facility that can adapt with the industry and your organization.